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Enterohemorrhagic Escherichia coli (EHEC) is an important foodborne pathogen causing gastroenteritis and more severe com-
plications, such as hemorrhagic colitis and hemolytic uremic syndrome. Pathology is most pronounced in the colon, but to date
there is no direct clinical evidence showing EHEC binding to the colonic epithelium in patients. In this study, we investigated
EHEC adherence to the human colon by using in vitro organ culture (IVOC) of colonic biopsy samples and polarized T84 colon
carcinoma cells. We show for the first time that EHEC colonizes human colonic biopsy samples by forming typical attaching and
effacing (A/E) lesions which are dependent on EHEC type III secretion (T3S) and binding of the outer membrane protein intimin
to the translocated intimin receptor (Tir). A/E lesion formation was dependent on oxygen levels and suppressed under oxygen-
rich culture conditions routinely used for IVOC. In contrast, EHEC adherence to polarized T84 cells occurred independently of
T3S and intimin and did not involve Tir translocation into the host cell membrane. Colonization of neither biopsy samples nor
T84 cells was significantly affected by expression of Shiga toxins. Our study suggests that EHEC colonizes and forms stable A/E
lesions on the human colon, which are likely to contribute to intestinal pathology during infection. Furthermore, care needs to
be taken when using cell culture models, as they might not reflect the in vivo situation.
Enterohemorrhagic Escherichia coli (EHEC) is a major cause ofbacterial diarrhea in the developed world, and infections can
lead to acute gastroenteritis, hemorrhagic colitis (HC), and sys-
temic hemolytic uremic syndrome (HUS) (1–3). HC and HUS are
associated with the release of bacterial Shiga toxins (Stxs), which
primarily affect the kidneys and central nervous system, which
express large amounts of the Stx glycolipid receptor globotriaosyl-
ceramide (Gb3) (4, 5). In contrast, the development of diarrhea is
linked to a type III secretion system (T3SS), which enables the
bacteria to colonize human intestinal epithelium and modulate
host cell signal transduction by injecting bacterial effector pro-
teins (6, 7). Initial events of type III secretion (T3S) comprise the
formation of the EspA translocation tube and delivery of the
translocated intimin receptor (Tir) into the host cell membrane
(8, 9). This is followed by binding of the bacterial outer membrane
adhesin intimin to Tir, which initiates formation of attaching and
effacing (A/E) lesions (10). EHEC A/E lesion formation has been
demonstrated in cultured cell lines and some animal models and is
characterized by intimate attachment, microvillous effacement,
and actin polymerization beneath adherent bacteria (11–14).
Whereas microscopy has demonstrated adherent EHEC in the
small intestine and the colon of gnotobiotic piglets, neonatal
calves, and infant rabbits (12–14), similar direct evidence of
EHEC binding to human colonic epithelium is lacking (15). This
is surprising, as EHEC predominantly causes a colonic pathology
in humans (15, 16), but the limited numbers of biopsy samples
available in the early stages of EHEC disease, before the occur-
rence of extensive tissue damage, no doubt contribute to the lack
of such evidence. In vitro organ culture (IVOC) of human endo-
scopic biopsy samples has been employed to investigate EHEC
adherence, and these studies using Stx-negative EHEC strains
and oxygen-rich culture conditions have demonstrated A/E le-
sion formation on the terminal ileum but not the colon (17,
18).
In the present study, we have reexamined EHEC adherence to
colonic epithelium using EHEC wild-type strains and atmo-
spheric oxygen levels (i.e., 20% atmospheric pressure). As it has
previously been shown that Stxs promote EHEC adherence to
HeLa cells and intestinal colonization in mice (19), we sought to
determine whether Stx expression would also enable EHEC bind-
ing to human colonic epithelium. In addition, IVOC experiments
are usually performed under oxygen-rich culture conditions (95%
atmospheric pressure) to allow oxygen penetration into deeper
tissues, but our earlier studies have demonstrated that oxygen
inhibits EHEC T3S and A/E lesion formation (20), which might
explain the lack of colonic adherence observed in previous IVOC
studies. In addition to investigating EHEC adherence to human
colonic explants, we have also included T84 human colon carci-
noma cells, which are widely used as an in vitro model for colonic
EHEC infection.
MATERIALS AND METHODS
Bacterial strains and culture conditions.The bacterial strains used in this
study are listed in Table 1. Bacteria were grown while they were standing in
LB broth overnight at 37°C. Deletion mutants (except EDL933 espA)
were selected with kanamycin (50 g/ml). Bacteria were spun down be-
fore infection and suspended in serum-free culture medium.
Received 17 November 2014 Returned for modification 12 December 2014
Accepted 19 December 2014
Accepted manuscript posted online 22 December 2014
Citation Lewis SB, Cook V, Tighe R, Schüller S. 2015. Enterohemorrhagic
Escherichia coli colonization of human colonic epithelium in vitro and ex vivo.
Infect Immun 83:942–949. doi:10.1128/IAI.02928-14.
Editor: B. A. McCormick
Address correspondence to Stephanie Schüller, stephanie.schuller@ifr.ac.uk.
Copyright © 2015, Lewis et al. This is an open-access article distributed under the
terms of the Creative Commons Attribution 3.0 Unported license.
doi:10.1128/IAI.02928-14
942 iai.asm.org March 2015 Volume 83 Number 3Infection and Immunity
 o
n







Cell culture and infection. Human colon carcinoma T84 cells (ATCC
CCL248) were cultured in Dulbecco’s modified Eagle’s medium/F-12 nu-
trient mixture supplemented with 10% fetal bovine serum (Sigma) and
used between passages 49 and 65. Cells were seeded out in 24-well plates at
a density of 105 cells/well and grown for 7 days for full confluence. For
Transwell experiments, 5  105 cells/insert were seeded on collagen-
coated Transwell filter inserts (diameter, 12 mm; pore size, 0.4m; Corn-
ing Costar). Transepithelial electrical resistance was monitored using an
EVOM2 resistance meter with an STX2 electrode (World Precision In-
struments), and values above 1,500 · cm2 after 7 to 10 days of differen-
tiation indicated establishment of epithelial barrier function. Confluent
or polarized T84 cells were infected with approximately 2 107 or 6 107
bacteria, respectively, and incubated for the time periods indicated below.
Medium was exchanged at regular intervals to prevent bacterial over-
growth and acidification. Cells were incubated at 37°C in a 5% CO2 at-
mosphere. At the end of the experiment, cells were washed twice in phos-
phate-buffered saline (PBS) to remove nonadherent bacteria and
processed according to the need for further analysis.
Quantification of adherent bacteria on polarized T84 cells. Cell
monolayers on filters were lysed in 1% Triton X-100 in PBS for 10 min.
Serial dilutions of lysates were plated out on LB agar plates, and the num-
bers of CFU were determined after overnight incubation at 37°C.
In vitro organ culture. This study was performed with approval from
the University of East Anglia Faculty of Medicine and Health Ethics Com-
mittee (reference 2010/11-030). All samples were provided through the
Norwich Biorepository, which has NRES approval (reference 10/H0310/
21). Biopsy samples from the terminal ileum or transverse colon were
obtained with informed consent during colonoscopy of 14 adult patients
(27 to 74 years old) and 2 pediatric patients (9 and 13 years old). Samples
were taken from macroscopically normal areas, transported to the labo-
ratory in IVOC medium, and processed within the next hour. IVOC was
performed as described previously (21). Briefly, biopsy samples were
mounted on foam supports in 12-well plates and incubated with 25 l of
a bacterial overnight culture (approximately 107 bacteria). Samples were
incubated in air–5% CO2 or 95% oxygen–5% CO2 at 37°C on a rocking
platform for 8 h. At the end of the experiment, biopsy samples were
washed twice in PBS to remove mucus and nonadherent bacteria and
processed according to the need for further analysis.
Scanning electronmicroscopy. Samples were fixed with 2.5% glutar-
aldehyde in PBS and dehydrated through a graded acetone series. Speci-
mens were dried using tetramethylsilane (Sigma), mounted on aluminum
stubs, sputter coated with gold (Polaron SC7640 sputter coater; Quorum
Technologies), and viewed with a JEOL JSM 4900 LV or Zeiss Supra 55 VP
FEG scanning electron microscope. Bacterial adherence to biopsy sample
epithelium was quantified by recording the presence or absence of adher-
ent bacteria within approximately 250 fields of view of 50 by 35 m2
covering the whole biopsy sample surface.
Transmission electron microscopy. Biopsy samples were fixed in
2.5% glutaraldehyde in 0.1 M PIPES [piperazine-N,N=-bis(2-ethanesul-
fonic acid)] buffer, postfixed in 1% aqueous osmium tetroxide, and de-
hydrated through a graded ethanol series. After embedding in LR White
medium-grade resin, 1-m semi-thin sections were cut with an ultrami-
crotome and stained with toluidine blue to locate adherent bacteria. Ul-
trathin sections (90 nm) were prepared from areas of interest, stained
sequentially with uranyl acetate and lead citrate, and examined in an FEI
Tecnai G2 20 Twin transmission electron microscope at 200 kV.
Immunofluorescence staining. Samples were fixed in 3.7% formal-
dehyde in PBS for 20 min and blocked/permeabilized with 0.1% Triton
X-100 and 0.5% bovine serum albumin in PBS for 20 min. Samples were
subsequently incubated in primary antibodies (goat anti-E. coli from Ab-
cam; rabbit anti-EspA from Gad Frankel, Imperial College London;
mouse anti-Tir from John Leong, Tufts University, USA) for 60 min,
washed, and incubated in Alexa Fluor-conjugated secondary antibodies
(Invitrogen) for 30 min. Filamentous actin was labeled with fluorescein
isothiocyanate-conjugated phalloidin (Sigma). Samples were mounted in
Vectashield medium (Vector Laboratories) and analyzed using a fluores-
cence light microscope (Axiovert 200M; Zeiss).
Statistics. All data are shown as means standard errors of the means
(SEMs). Statistical analysis was performed using GraphPad Prism (ver-
sion 5) software. Student’s t test or one-way analysis of variance with
Tukey’s multiple-comparison test was used to determine differences be-
tween two or multiple groups, respectively. A P value of0.05 was con-
sidered significant.
RESULTS
The EHEC adherence phenotype to T84 human colon carci-
noma cells is dependent on polarization status. To investigate
the adherence of EHEC to T84 cells, confluent cell monolayers
grown on coverslips were infected with Stx-negative strain
TUV93-0 for 5 h, and the adherence phenotype was investigated
by fluorescent actin staining and scanning electron microscopy. It
was noted that T84 cells in the center of the monolayer showed
signs of polarization, such as an actin-rich microvillous brush bor-
der, whereas cells at the margin of the coverslip appeared to be
undifferentiated with few microvilli (Fig. 1). While EHEC bacteria
adherent to marginal cells formed actin-rich pedestals, the bacte-
ria on central polarized cells were not associated with polymerized
actin but displayed signs of microvillous effacement (Fig. 1). Actin
pedestal formation in polarized T84 cells was not impaired or
obscured due to the high density of actin in the brush border, as
T84 cells infected with the related A/E pathogen enteropathogenic
E. coli (EPEC) showed actin recruitment on both polarized and
nonpolarized cells (data not shown). Experiments were extended
to EHEC wild-type strains EDL933 and Walla-1 using T84 cells
grown on Transwell inserts. In this culture system, T84 cells
reached full polarization status, as indicated by a high transepithe-
lial electrical resistance, a column-shaped morphology, an actin-
rich microvillous brush border, and the formation of tight junc-
tions (data not shown). Infections were performed for 5 to 9 h,
and no actin recruitment was observed for any of the strains tested
(Fig. 2).
EHEC colonizes human terminal ileal and colonic biopsy
samples. Colonization of human intestinal mucosa by wild-type
EHEC was investigated by infecting terminal ileal and transverse
colonic biopsy samples, taken from adults during routine endos-
copy, with strains EDL933, Walla-1, or H0-7184-0336 for 8 h.
Similar to T84 cell infections, IVOC was performed under atmo-
spheric oxygen concentrations (20%). Scanning electron micros-
copy analysis revealed colonization of ileal and colonic biopsy
TABLE 1 E. coli strains used in the study
Name Description Source or reference
EDL933 Wild-type EHEC O157:H7 50
EDL933 eae EDL933 eae deletion mutant 51
EDL933 escN EDL933 escN deletion mutant 52
EDL933 espA EDL933 espA deletion mutant 53
EDL933 stx EDL933 stx1 stx2 deletion
mutant
54




85-170 Stx-negative derivative of EHEC
O157:H7 84-289
55
Walla-1 EHEC O157:H7 56
H0-7184-0336 EHEC O157:H7 G. Smith, Public Health
England
E2348/69 EPEC O127:H6 57
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samples by all strains (Fig. 3A and B; representative images are
shown for EDL933). Similar to previous IVOC studies, extensive
elongation of microvilli adjacent to adherent EHEC was observed
on ileal biopsy samples (Fig. 3A). On colonic biopsy samples, mi-
crovillous effacement was apparent next to adhering bacteria, and
surrounding microvilli displayed a normal length, which was sim-
ilar to the phenotype observed on polarized T84 cells (Fig. 3B).
Colonic EHEC colonization has not been observed in previous
IVOC studies using pediatric samples (17, 18). To examine
whether young donor age was the reason for the lack of EHEC
adherence, we also performed IVOC experiments using pediatric
biopsy samples. Scanning electron microscopy analysis of
EDL933-infected colonic biopsy samples demonstrated EHEC ad-
herence similar to that in adult tissue samples (Fig. 3C).
EHEC colonization of human colonic epithelium is not af-
fected by Shiga toxin production. Previous IVOC studies on Stx-
negative EHEC have failed to show the direct colonization of co-
lonic biopsy samples (17, 18). As Stxs have been implicated in
EHEC adherence to human epithelial cells and colonization of
mouse intestine (19), we investigated whether Stx production was
required for colonic binding. IVOC of colonic biopsy samples
with Stx-negative strains TUV93-0 and 85-170 (used in previous
studies) was performed. As shown in Fig. 4A, both strains showed
good colonic colonization with a phenotype similar to that of
wild-type EHEC strains.
In addition, adherence of EDL933 and an isogenic Stx-deletion
mutant to colonic biopsy samples and polarized T84 cells was
quantified. Figures 4B and C show that there was no significant
difference in the number of cell-associated bacteria between the
two strains (P 0.24 and P 0.1236, respectively).
Involvement of EHECT3S in colonic adherence. We next de-
termined whether EHEC adherence to colonic epithelium was de-
pendent on T3S or intimin. IVOC of colonic biopsy samples was
performed using EDL933 mutants deficient in EspA (the translo-
cation filament), EscN (the cytoplasmic ATPase of the T3SS), or
intimin, and colonization was evaluated by scanning electron mi-
croscopy. As shown in Fig. 5, all mutants failed to colonize,
whereas the wild type showed good adherence. Quantification of
FIG 1 Different adherence phenotypes of EHEC on polarized and nonpolar-
ized T84 cells. Confluent T84 cells on coverslips were infected with strain
TUV93-0 for 5 h. Shown are representative images from two independent
experiments performed in duplicate. (A) Immunofluorescence staining for
actin (green) and E. coli (red). (Top) Merged images; (bottom) actin staining
as a separate channel. Bars  10 m. (B) Scanning electron micrographs
showing EHEC-associated microvillous effacement (white arrows) on polar-
ized cells and actin pedestal formation (black arrows) on nonpolarized cells.
Bars 2 m.
FIG 2 EHEC bacteria do not recruit actin in polarized T84 cells. T84 cells
differentiated on Transwell membranes were infected with strain EDL933 or
Walla-1 for 5 to 9 h. Immunofluorescence staining for actin (green) and E. coli
(red). (Right) Merged images; (left) actin staining as a separate channel. Rep-
resentative images after 9 h of infection from two independent experiments
performed in duplicate. Bars 5 m.
FIG 3 EHEC bacteria colonize human ileal and colonic biopsy samples. En-
doscopic biopsy samples from the terminal ileum or transverse colon were
infected with EDL933 for 8 h. (A) Scanning electron micrograph showing
EHEC bacteria adhering to the terminal ileum and surrounded by elongated
microvilli. (B) On the colon, a zone of microvillous effacement (arrows) was
evident around adhering bacteria, and adjacent microvilli displayed a normal
length. (C) An adherence phenotype similar to that shown in panel B was
evident on pediatric colonic biopsy samples. Images are representative of those
from three (A and B) and two (C) independent experiments performed in
duplicate. Bars 2 m.
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colonized sample areas yielded 25.99% 7.19% for the wild type,
whereas no areas with adherent bacteria (0%) were detected for
any of the mutant strains. Immunofluorescence staining and
transmission electron microscopy were subsequently used to eval-
uate A/E lesion formation. As shown in Fig. 6, adherent EHEC
bacteria were associated with EspA filaments and translocated Tir
and demonstrated intimate attachment and microvillous efface-
ment. In contrast, adherence of EDL933 to polarized T84 cells was
not significantly affected by the absence of EspA, EscN, or intimin
(Fig. 7A). Immunofluorescence staining of EDL933-infected po-
larized T84 cells demonstrated the formation of EspA filaments,
but translocated Tir was absent in monolayer-associated cells (Fig.
7B) and detected only in detaching cells which had lost cell polar-
ity (data not shown).
High levels of oxygen suppress EHEC adherence and A/E le-
sion formation on human colonic biopsy samples. Our previous
studies have demonstrated inhibition of EHEC T3S and A/E lesion
formation on polarized T84 cells by oxygen (20). To investigate
whether oxygen also affected EHEC A/E lesion formation on co-
lonic biopsy samples and might explain the lack of colonization
observed in previous studies (17, 18), IVOC was performed under
high (95%, as in previous studies [17, 18]) or atmospheric (20%,
as in this study) oxygen levels. As shown in Fig. 8, colonization of
EDL933 was significantly inhibited under oxygen-rich conditions.
We also performed IVOC under microaerobic (	1.5% oxy-
gen) conditions similar to those in the environment in the human
colon but observed severe epithelial cell extrusion even on nonin-
fected samples after 5 h of incubation (data not shown).
DISCUSSION
EHEC is considered a colonic pathogen, and the clinical histopa-
thology of HC is predominantly observed in the ascending and
transverse colon (1, 22). However, the intestinal pathogenesis of
EHEC has not been well explored, and this is partly due to the lack
of suitable animal model systems. Major obstacles include the
failure of EHEC to efficiently colonize the mouse or rabbit intes-
FIG 4 Colonization of colonic epithelium by EHEC is not affected by Stx
production. (A) Scanning electron microscopy of biopsy samples from the
transverse colon infected with Stx-negative strain TUV93-0 or 85-170 for 8 h.
Images are representative of those from two independent experiments per-
formed in duplicate. Bar  2 m. (B) Colonic biopsy samples were infected
with wild-type (WT) EDL933 or an isogenic Stx deletion mutant (stx) for 8 h.
Samples were viewed by scanning electron microscopy, and epithelial coloni-
zation was quantified by recording the presence or absence of adherent bacte-
ria in approximately 250 fields of view. Colonization is expressed as the per-
centage of the fields of view containing adherent bacteria. Data are shown as
means  SEMs from two independent experiments performed in triplicate.
(C) Polarized T84 cells were infected with wild-type EDL933 or EDL933 stx
for 6 h. The numbers of adherent bacteria were quantified by plating serial
dilutions of cell lysates and determining the numbers of CFU. Colonization is
expressed as the percentage of adherent bacteria relative to the inoculum. Data
are shown as means SEMs from five independent experiments performed in
duplicate.
FIG 5 EHEC colonization of colonic biopsy samples is dependent on intimin
and T3S. Scanning electron micrographs of biopsy samples from the transverse
colon infected with wild-type (WT) EDL933 or isogenic EspA, EscN, or in-
timin (eae) mutants for 8 h. Images are representative of those from four
independent experiments performed in duplicate. Bars 10 m.
FIG 6 EHEC bacteria form typical A/E lesions on human colonic biopsy
samples. Colonic biopsy samples were infected with EDL933 for 8 h. Immu-
nofluorescence staining was performed for EspA (A) or Tir (B) in green and E.
coli in red. (C) Transmission electron micrograph showing intimate EHEC
adherence to host cell membrane and loss of microvilli. Images are represen-
tative of those from two independent experiments performed in duplicate.
Bars 2 m (A, B) or 0.5 m (C).
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tinal tract without prior removal of the resident microflora (23)
and the expression of the Stx receptor Gb3 by mouse and rabbit
intestinal epithelium, in contrast to the situation in humans (24–
26). Therefore, cell culture models have been widely applied, and
the T84 human colon carcinoma cell line has been used in many
EHEC studies, as it has the structural characteristics of colonic
crypt cells (27) and, like human intestinal epithelium, does not
express significant amounts of Gb3 and is resistant to Stx cytotox-
icity (26).
In our study, we have found that EHEC bacteria adhering to
polarized T84 cells do not form typical A/E lesions. While forma-
tion of the EspA filament and microvillous effacement were evi-
dent, no Tir translocation or actin polymerization was detected in
association with adherent bacteria. In addition, EHEC coloniza-
tion was not significantly affected by the absence of EspA, intimin,
or T3S, which suggests the involvement of other adherence fac-
tors, such as fimbriae, autotransporters, or flagella (28). These
findings are consistent with those of previous studies, which have
failed to detect EHEC actin pedestals in confluent T84 cells (29,
30). Interestingly, EHEC bacteria were still able to modulate host
cell signal transduction and function, such as intracellular calcium
levels, epithelial barrier function, and ion transport, which sug-
gests that T3S into polarized T84 cells can occur independently of
the intimin-Tir interaction or actin polymerization (29–32).
It is currently unknown which bacterial factors cause microvil-
lous effacement during EHEC infection, but findings on the re-
lated A/E pathogen EPEC appear to be dependent on the model
system used, with adherence phenotypes even differing between
Caco-2 cell subclones (33). Whereas microvillous effacement and
bacterial sinking in Caco-2 cells have been reported to be depen-
dent on intimin and Tir (34), EPEC mutants with mutations in
intimin or Tir still cause microvillous effacement and effacing
footprints in pediatric duodenal IVOC (35). On the other hand,
EPEC microvillous effacement in porcine ileal IVOC appears to be
intimin dependent but independent of Tir (36). Our study on
polarized T84 cells demonstrates that EHEC effacement can occur
independently of Tir translocation into the host cell membrane.
A different EHEC adherence phenotype was apparent on non-
polarized T84 cells at monolayer margins or on detaching cells,
where translocated Tir and actin pedestals were observed. This
could be due to the availability of phosphatidylethanolamine or
other receptors for EHEC binding which become exposed on the
cell surface after apoptosis or cell shedding (37, 38). The ability of
EPEC to form actin pedestals on polarized T84 cells suggests that
this pathogen uses different receptors for initial binding than
EHEC and that these receptors are readily expressed on the apical
cell membrane. Another possibility for the failure of EHEC to
form actin pedestals on polarized T84 cells might be related to
particular properties of the apical T84 cell membrane which
would prevent proper EHEC Tir insertion or clustering by in-
timin.
Despite the presence of colonic pathology, it has been contro-
versial whether EHEC can colonize human colonic epithelium in
vivo, as adherent bacteria have not been reported during clinical
infections (15, 39). It has been argued that this may be because of
the progressed stage of disease at the time of endoscopy, when
bacterial adhesion may have diminished or be difficult to identify
due to extensive tissue damage (1, 17). In contrast, EHEC infec-
tions in gnotobiotic piglets, infant rabbits, and neonatal calves
have shown colonization of the terminal ileum, cecum, and colon
(12–14, 40). Adherent bacteria were associated with characteristic
A/E lesions accompanied by intimate attachment and loss of mi-
crovilli, and adherence was dependent on intimin-Tir interaction
(12, 13, 41). Ileal and colonic A/E lesions have also been repro-
duced in bovine intestinal IVOC and shown to be dependent on
Tir (42). In contrast, human IVOC studies using pediatric biopsy
samples have demonstrated EHEC binding and A/E lesion forma-
tion on terminal ileum but not colon (17, 18). However, some
minimal nonintimate adherence to colonic explants was observed
after previous incubation of EHEC with terminal ileal biopsy sam-
FIG 7 Adherence of EHEC to polarized T84 cells is independent of intimin
and T3S and does not involve Tir translocation. (A) Polarized T84 cells were
infected with wild-type (WT) EDL933 or isogenic EspA, EscN, or intimin (eae)
mutants for 6 h. The numbers of adherent bacteria were quantified by plating
serial dilutions of cell lysates and determining the number of CFU. Coloniza-
tion is expressed as the percentage of adherent bacteria relative to the inocu-
lum. Data are shown as means  SEMs from four independent experiments
performed in duplicate. (B) Immunofluorescence staining of polarized T84
cells infected with EDL933 for 6 h. Green, EspA and Tir; red, E. coli. Images are
representative of those from two independent experiments performed in du-
plicate. Bars 5 m.
FIG 8 EHEC A/E lesion formation on colonic biopsy samples is suppressed by
oxygen-rich conditions. IVOC of colonic biopsy samples with EDL933 was
performed for 8 h under high (oxygen) or atmospheric (air) oxygen levels.
Samples were viewed by scanning electron microscopy, and epithelial coloni-
zation was quantified by recording the presence or absence of adherent bacte-
ria in approximately 250 fields of view. Colonization is expressed as the per-
centage of fields of view containing adherent bacteria. Data are shown as
means SEMs from two independent experiments performed in triplicate. *,
P 0.05.
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ples (17). These findings have led to the hypothesis that EHEC
initially colonizes the terminal ileum and Peyer’s patches, where
bacteria are primed for subsequent spread and infection of the
colon. Similar colonization dynamics have been described for the
mouse A/E pathogen Citrobacter rodentium, which demonstrates
primary adherence to the lymphoid cecal patch before establish-
ing colonization of the colon (43). Interestingly, a recent study
using human intestinal xenografts in mice has reported T3S-de-
pendent EHEC A/E lesion formation on human colon but not on
small intestine (44).
In our study, we have found EHEC colonization of human
terminal ileum and colon ex vivo. Typical A/E lesions similar to
those previously described on terminal ileal biopsy samples were
observed on colonic explants, demonstrating intimate attach-
ment, microvillous effacement, and Tir translocation beneath ad-
herent bacteria (18, 45). Interestingly, colonic A/E lesions were
not accompanied by elongation of the surrounding microvilli, as
observed on terminal ileum. This has also been observed on bo-
vine IVOC and human intestinal xenografts and might reflect dif-
ferences in the organization of the brush border cytoskeleton in
the small intestine and colon (42, 44). Similar to previous human
intestinal xenograft and animal studies, A/E lesion formation on
human colonic explants was dependent on T3S and intimin (13,
41, 44).
In addition to Tir, the host cell protein nucleolin has been
described to be a host receptor for intimin (46), and previous
studies have shown that Stxs enhance EHEC adherence to HeLa
cells and intestinal colonization of mice by inducing surface ex-
pression of nucleolin (19). As former human IVOC studies have
been performed with Stx-negative EHEC strains (17, 18), we in-
vestigated whether Stxs could promote colonic adhesion. Our
findings on Stx-negative mutants showed that Stx production did
not significantly affect EHEC adherence to human colonic epithe-
lium, which agrees with previous results in infant rabbits, where
Stx expression did not alter colonization levels (13).
Other differences from earlier human IVOC studies by Phillips
and colleagues (17, 18) which might explain the discrepancies in
colonic colonization include the use of adult versus pediatric bi-
opsy samples and lower oxygen concentrations during IVOC.
Whereas the influence of age on EHEC colonic infection has not
been investigated, IVOC studies with EPEC have demonstrated no
significant difference in EPEC binding to adult versus pediatric
biopsy samples (47). As we also observed EHEC colonization of
pediatric colonic biopsy samples, age was not the determining
factor for our findings.
In contrast, we found that the high oxygen levels (95%) com-
monly used in IVOC to ensure sufficient tissue oxygenation and
survival (21, 48) suppressed EHEC adherence to colonic biopsy
samples. This is in agreement with the findings of our previous
study demonstrating that lower oxygen levels promote EHEC ad-
herence and T3S on polarized T84 cells (20). Similar results have
been reported for bovine intestinal IVOC, where the EHEC colo-
nization observed with air (20% oxygen) was improved compared
with that achieved with 95% oxygen without compromising tissue
integrity (42). Lower oxygen levels are also likely to explain EHEC
A/E lesion formation in human colonic xenografts (44). Interest-
ingly, high oxygen levels did not abolish EHEC A/E lesion forma-
tion on terminal ileal biopsy samples (17, 18), suggesting higher
levels of adherence to the small intestine than to the colon. This
might be related to a thinner mucus layer with less microbiota and
easier access to the epithelium (49).
In summary, our study demonstrates for the first time that
EHEC forms typical A/E lesions on human colon ex vivowhich are
dependent on T3S and intimin. Importantly, A/E lesion forma-
tion is dependent on oxygen levels and suppressed by the oxygen-
rich culture conditions generally used in IVOC. In contrast, ad-
herence to polarized T84 cells is mediated by factors other than
EspA and intimin and does not involve Tir translocation into the
host cell membrane. This study emphasizes the difference be-
tween cell culture experiments and more relevant model sys-
tems, such as IVOC, and suggests that during human infection
EHEC forms stable A/E lesions which are likely to contribute to
colonic pathology.
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